Arquitos Capital Partners has reported exceptional performance for 2025, with the investment management firm delivering an 82.1% net return to investors. The fund significantly outperformed…
Aflac executives outlined strong performance across both Japan and U.S. markets during a recent UBS investor conference, highlighting record shareholder returns and continued sales momentum in supplemental insurance. The insurance giant returned nearly $4.8 billion…
Investor concerns over artificial intelligence disruption sent shockwaves across multiple industries last week, causing significant losses in sectors ranging from technology to wealth management and logistics. The AI disruption fears, which initially centered on software companies, have now spread to high-fee service businesses, raising questions about how deeply automation could…
STERIS plc, a leading provider of infection prevention and procedural support solutions, has retained analyst confidence following its third-quarter fiscal 2026 financial results. On February 5, Citizens JMP Securities reiterated its Market Outperform rating on STERIS plc and maintained a $280 price target on the medical technology stock. The firm’s…
Current mortgage rates have dropped to their lowest levels in years, presenting potential opportunities for homebuyers and homeowners considering refinancing. According to the latest data from the Zillow lender marketplace, the average 30-year fixed mortgage rate stands at 5.85%, while Freddie Mac reports a slightly higher rate of 6.09%. These…
Savings account interest rates continue to offer significant returns compared to historical averages, though rates have been gradually declining from their recent peaks. As of February 15, 2026, the highest savings account rate available stands at 4% APY, offered by several financial institutions including SoFi, Valley Bank Direct, and Barclays.…
Spotlight
Business
More ArticlesMarkets
More ArticlesPersonal Finance
More ArticlesImvesting
More ArticlesPharmaceutical giant Merck & Co Inc continues to draw attention from market analysts as the company navigates a transforming healthcare landscape marked by patent expirations and an evolving product portfolio. Recent analyst reports have highlighted…














































































